Virtual CME Program
1.00 CME/CE Credit
Harnessing Digital Diabetes Technology for Successful Insulin Management: An Integrated Approach
Insulin remains essential in managing type 2 diabetes mellitus (T2DM), yet barriers often delay its initiation and intensification. This 60-minute virtual CME session, led by expert faculty, will explore strategies to overcome these challenges and optimize insulin use in clinical practice.
The session will also examine how digital health technologies can support self-management, improve insulin adherence, increase time in range (TIR), and reduce hypoglycemia. Faculty will further discuss the emerging role of once-weekly insulins and how technology can help integrate these therapies into personalized care.
CME/CE Information
1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.75 AANP Pharm
Release Date: 10/15/2025
Expiration Date: 10/15/2026
Learning Objectives
- Describe the role of insulin therapy in effective diabetes management and common barriers to its initiation and intensification
- Leverage digital technology in type 2 diabetes (T2DM) to facilitate self-management, improve insulin adherence, and reduce therapeutic inertia
- Employ digital technology to improve time in range (TIR) and reduce hypoglycemia Examine emerging once-weekly insulins and the role that diabetes technology can play in optimizing their use
Faculty
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
Director, Riverside Diabetes Center, Riverside Medical Associates, Riverdale, Maryland
Learn More
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES
Endocrine Clinical Pharmacy Specialist, Department of Endocrinology, Diabetes & Metabolism, CGM Program Coordinator, Cleveland Clinic
Learn MoreDisclosures
The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC: Advisor for Abbott Diabetes Care, Novo Nordisk, Sanofi; Consultant for Abbott Diabetes Care, Novo Nordisk, Sanofi, Nestle; Speaker for Abbott Diabetes Care, Novo Nordisk, Sanofi
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES: Consultant for Dexcom, Sequel, Medtronic, Tandem; Speaker for Dexcom, Novo Nordisk, Lilly, Sanofi, Sequel, Medtronic, Insulet
Pamela Kushner, MD, FAAFP (Moderator): Advisor for GlaxoSmithKline, Boehringer Ingelheim, Novo Nordisk, AstraZeneca, Abbott, Corcept; Speaker for GlaxoSmithKline, Janssen, Boehringer Ingelheim, Astellas, Novo Nordisk, Lilly, AstraZeneca, Bayer, Corcept
All others in control of content for this activity have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and the Association of Diabetes Care & Education Specialists. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.
In support of improving patient care, this activity has been planned by Pri-Med Institute and the Association of Diabetes Care & Education Specialists. Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
Accreditation Council for Pharmacy Education
The Universal Activity Number is JA4008258-9999-25-291-L01-P. This knowledge-based activity has been approved for 1.00 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
American Medical Association (AMA)
Association of Diabetes Care & Education Specialists designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.00 ANCC contact hours. This activity discusses 0.75 contact hours of pharmacotherapeutic content.
The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.00 contact hours. RNs must retain this document for 4 years after the activity concludes.
The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This live activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Commission on Dietetic Registration (CDR): CDR Credentialed Practitioners will receive 1 Continuing Professional Education units (CPEUs) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.
Certified Diabetes Care and Education Specialists: To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (http://www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.
Other Health Professionals: It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.
Designation Statement
This activity is approved for 1.00 contact hour of continuing education, which includes 0.75 hours of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Instructions for Obtaining Credit
Supporters and Partners
Supported by
Novo Nordisk Inc.Education Partner
Association of Diabetes Care & Education SpecialistsFine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.